Double-blind, Randomized, Placebo-controlled, Phase III Study Comparing norUrsodeoxycholic Acid Capsules With Placebo in the Treatment of Primary Sclerosing Cholangitis
Latest Information Update: 08 Aug 2024
Price :
$35 *
At a glance
- Drugs Norursodeoxycholic acid (Primary)
- Indications Primary sclerosing cholangitis
- Focus Registrational; Therapeutic Use
- Sponsors Dr Falk Pharma
- 06 Aug 2024 Planned End Date changed from 1 Dec 2023 to 1 Jun 2026.
- 06 Aug 2024 Planned primary completion date changed from 1 Apr 2021 to 1 Jan 2025.
- 06 Aug 2024 Status changed from recruiting to active, no longer recruiting.